SG11201407828SA - Anti-ageing composition containing dehydrogenated abietic acid as active ingredient - Google Patents

Anti-ageing composition containing dehydrogenated abietic acid as active ingredient

Info

Publication number
SG11201407828SA
SG11201407828SA SG11201407828SA SG11201407828SA SG11201407828SA SG 11201407828S A SG11201407828S A SG 11201407828SA SG 11201407828S A SG11201407828S A SG 11201407828SA SG 11201407828S A SG11201407828S A SG 11201407828SA SG 11201407828S A SG11201407828S A SG 11201407828SA
Authority
SG
Singapore
Prior art keywords
gyeonggi
active ingredient
abietic acid
composition containing
ageing
Prior art date
Application number
SG11201407828SA
Other languages
English (en)
Inventor
Young Gyu Kang
Jun Seong Park
Jin Sup Shim
Kyeong Hwan Hwang
Joon Ho Park
Myeong Hun Yeom
Jun Cheol Cho
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of SG11201407828SA publication Critical patent/SG11201407828SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201407828SA 2012-05-24 2013-05-15 Anti-ageing composition containing dehydrogenated abietic acid as active ingredient SG11201407828SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120055099A KR101349248B1 (ko) 2012-05-24 2012-05-24 탈수소 아비에틱산을 유효성분으로 함유하는 항노화용 조성물
PCT/KR2013/004317 WO2013176435A1 (ko) 2012-05-24 2013-05-15 탈수소 아비에틱산을 유효성분으로 함유하는 항노화용 조성물

Publications (1)

Publication Number Publication Date
SG11201407828SA true SG11201407828SA (en) 2015-01-29

Family

ID=49624063

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407828SA SG11201407828SA (en) 2012-05-24 2013-05-15 Anti-ageing composition containing dehydrogenated abietic acid as active ingredient

Country Status (9)

Country Link
US (1) US20150164754A1 (zh)
JP (1) JP2015517567A (zh)
KR (1) KR101349248B1 (zh)
CN (1) CN104334153B (zh)
HK (1) HK1201188A1 (zh)
MY (1) MY166900A (zh)
PH (1) PH12014502627A1 (zh)
SG (1) SG11201407828SA (zh)
WO (1) WO2013176435A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101970504B1 (ko) * 2012-09-12 2019-04-19 (주)아모레퍼시픽 탈수소아비에틱산을 유효성분으로 함유하는 피부 미백용 조성물
CN105193870A (zh) * 2015-10-30 2015-12-30 中国科学院昆明植物研究所 华山松松脂提取物及以其为活性成分的化妆品和应用
KR102081204B1 (ko) 2016-09-08 2020-02-25 (주)아모레퍼시픽 탈수소 아비에틱산 및 컴파운드 k를 포함하는 피부 항노화용 조성물
KR102611023B1 (ko) * 2018-11-21 2023-12-08 (주)아모레퍼시픽 탈수소 아비에틱산을 포함하는 피부 장벽 강화용 또는 보습용 피부 외용제 조성물
KR102100646B1 (ko) 2018-12-11 2020-05-15 김경호 록샘파이어의 캘러스 배양물인 줄기세포 스템셀을 포함하는 화장료 조성물
KR102165505B1 (ko) 2018-12-18 2020-10-14 김경호 규산염 및 히알루론산을 포함하는 화장료 조성물
KR102298449B1 (ko) 2019-08-02 2021-09-07 김경호 포포나무 추출물 및 록샘파이어의 캘러스 배양물인 줄기세포 스템셀을 포함하는 화장료 조성물
CN112175243B (zh) * 2020-09-21 2023-05-05 桂林理工大学 一种高性能醋酸纤维素复合材料及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2523299B2 (ja) * 1987-01-23 1996-08-07 株式会社資生堂 皮膚外用剤
JPH0798730B2 (ja) * 1987-01-23 1995-10-25 株式会社資生堂 皮膚外用剤
JP3632951B2 (ja) * 1999-03-03 2005-03-30 株式会社資生堂 マトリックスメタロプロテアーゼ阻害剤
JP2001139466A (ja) * 1999-11-11 2001-05-22 Shiseido Co Ltd マトリックスメタロプロテアーゼ活性阻害剤および抗老化用化粧料
JP2001192316A (ja) * 2000-01-06 2001-07-17 Shiseido Co Ltd マトリックスメタロプロテアーゼ阻害剤
JP4796734B2 (ja) * 2002-03-19 2011-10-19 株式会社ディーエイチシー マトリックスメタロプロテアーゼ活性阻害剤
US7015248B2 (en) * 2002-09-26 2006-03-21 Xiamen Ever-Health Bio-Tech. Co. Ltd Use of abietic acid and derivatives thereof for inhibiting cancer
JP2005132768A (ja) * 2003-10-30 2005-05-26 Sunstar Inc 口腔用組成物
KR100721421B1 (ko) * 2005-03-29 2007-05-28 주식회사 한생화장품 항균 및 항진균 활성을 갖는 솔방울 추출물, 및 이를유효성분으로 하는 피부질환 개선용 화장료 조성물
JP2006312588A (ja) * 2005-05-06 2006-11-16 Sunstar Inc 口腔用組成物
JP5366358B2 (ja) * 2006-09-29 2013-12-11 株式会社コーセー 皮膚の老化機構に作用する剤、抗老化用皮膚外用剤、及び抗老化方法
JP2009091283A (ja) * 2007-10-05 2009-04-30 Pola Chem Ind Inc マトリックスメタロプロテアーゼ及びこれを含有する組成物
KR20090080153A (ko) * 2008-01-21 2009-07-24 주식회사 엘지생활건강 피부 주름개선 또는 피부 미백용 조성물
KR101027113B1 (ko) * 2008-05-28 2011-04-05 주식회사 코씨드바이오팜 해송의 송기 추출물을 함유하는 화장료 조성물의 제조방법
KR101119288B1 (ko) * 2008-06-24 2012-03-15 (주)아모레퍼시픽 송절 추출물을 유효성분으로 함유하는 피부 외용제 조성물및 그의 제조방법
JP5590286B2 (ja) * 2009-09-04 2014-09-17 国立大学法人岩手大学 新規なＣａ２＋シグナル伝達阻害剤
JP2011178747A (ja) * 2010-03-03 2011-09-15 Fujifilm Corp マトリックスメタロプロテアーゼ（ｍｍｐ）産生阻害剤
KR20120049589A (ko) * 2010-11-09 2012-05-17 (주)아모레퍼시픽 표면이 개질된 화장료용 안료 및 개질된 안료를 함유하는 메이크업 화장료 조성물

Also Published As

Publication number Publication date
KR20130131507A (ko) 2013-12-04
JP2015517567A (ja) 2015-06-22
US20150164754A1 (en) 2015-06-18
CN104334153A (zh) 2015-02-04
CN104334153B (zh) 2018-02-13
HK1201188A1 (zh) 2015-08-28
WO2013176435A1 (ko) 2013-11-28
PH12014502627B1 (en) 2015-02-02
MY166900A (en) 2018-07-24
KR101349248B1 (ko) 2014-01-13
PH12014502627A1 (en) 2015-02-02

Similar Documents

Publication Publication Date Title
SG11201407828SA (en) Anti-ageing composition containing dehydrogenated abietic acid as active ingredient
SG11201808476SA (en) Recycling of polymer matrix composite
SG11201804672QA (en) Systems and methods for production of low oxygen content silicon
CA2859619C (en) Bromodomain inhibitors
SG11201808108XA (en) Synthesis of indazoles
SG11201408303WA (en) Adhesive compositions of propylene-based and ethylene-based polymers
SG11201407579QA (en) Interleukin-2 fusion proteins and uses thereof
SG11201407546QA (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
SG11201408297XA (en) Porous graphene oxide materials
SG11201804223TA (en) OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF
SG11201804888WA (en) Velocity model update with an inversion gradient
SG11201407728RA (en) Pul-core method with a pmi foam core
SG11201407988UA (en) Process for improved opioid synthesis
SG11201901986SA (en) Process for the manufacture of a solid pharmaceutical adminstration form
SG11201805052YA (en) Therapeutic methods using erythrocytes
SG11201408292YA (en) Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same
SG11201407591PA (en) Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
SG11201408343TA (en) Phosphorus-containing epoxy resin, composition containing phosphorus-containing epoxy resin as essential component, and cured product
SG11201806393QA (en) Use of gabaa receptor modulators for treatment of itch
SG11201407679PA (en) Manufacture of degarelix
SG11201408509PA (en) Racecadotril lipid compositions
SG11201804630SA (en) Preparation process for polypropylene with enhanced visual appearance
SG11201406745VA (en) Methods of therapeutic monitoring of phenylacetic acid prodrugs
SG11201406978RA (en) Stable polymerizable uv-absorbing colorant for intraocular lens
SG11201805142RA (en) Pharmaceutical compositions comprising phenylaminopyrimidine derivative